0       0

HFSA's 19th Annual Scientific Meeting


From Bench to Bedside: Emerging Therapies for the Failing Myocardium


Sep 27, 2015 3:30pm ‐ Sep 27, 2015 5:00pm

Description

Identify emerging therapies for the failing myocardium, and discuss their implications for clinical practice.

Speaker Objective(s):

  • Targeting Calcium Handling Defects (with Gene Therapy)
  • Targeting Abnormal Cardiac Metabolism
  • Targeting Fibrosis in the Failing Heart
  • Targeting Pathological Hypertrophy
  • Targeting Cell Death Pathways
  • GRK2 Inhibition as an Emerging Heart Failure Therapy

Speaker(s):

Moderator(s):

  • Michael Bristow, MD, PhD, Professor of Medicine (Cardiology), University of Colorado, Aurora AMC and Boulder
  • Kenneth Margulies, MD, FHFSA, Professor of Medicine, University of Pennsylvania, Perelman School of Medicine

You must be logged in and own this session in order to post comments.

Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content
token-index
token-content